Klionsky DJ. et al.
[2016]. Guidelines for the use and interpretation of assays form monitoring autophagy (3rd edition). Autophagy 12(1):1-222
Corvillo F., Bravo García-Morato M., Nozal P., Garrido S., Tortajada A., Rodríguez de Córdoba S. and López-Trascasa M.
[2016]. Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy. Clin. Exp. Immunol. 184:118-125
Recalde S., Tortajada A., Subias M., Anter J., Blasco M., Maranta R., Coco R., Pinto S., Noris M., García-Layana A. and Rodríguez de Córdoba S.
[2016]. Molecular basis of Factor H R1210C association with ocular and renal diseases. J. Am. Soc. Nephrol. 27:1305-1311
Rodríguez de Córdoba S.
[2016]. Complement genetics and susceptibility to inflammatory disease. Lessons from genotype-phenotype correlations. Immunobiology. 221:709-714
Campistol JM., Arias M., Ariceta G., Blasco M., Espinosa L., Espinosa M., Grinyó JM., Macía M., Mendizábal S., Praga M., Román E., Torra R., Valdés F., Vilalta R. and Rodríguez de Córdoba S.
[2015]. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document (Actualización en síndrome hemolítico urémico atípico: diagnóstico y tratamiento. Documento de consenso) Nefrología. 35:421-447
Alcorlo M., López-Perrote A., Delgado Bermúdez S., Yébenes H., Subías M., Rodríguez-Gallego C., Rodríguez de Córdoba S. and Llorca O.
[2015]. Structural Insights on Complement Activation. FEBS Journal. 282:3883-3891
Rabasco C, CaveroT, Román E, Rojas-Rivera J, Olea T, Espinosa M, Cabello V, Fernández-Juárez G, González F, Avila A, Baltar JM, Díaz M, Alegre R, Elías S, Antón M, Frutos MA, Pobes A, Blasco M, Martín F, Bernis C, Rodriguez de Cordoba S, Praga M & GLOSEN.
[2015]. Effectiveness of Mycophenolate Mofetil in C3 Glomerulonephritis. Kidney International. 88:1153-1160
Bernabéu-Herrero ME., Jiménez-Alcázar M., Anter J., Pinto S., Sánchez-Chinchilla D., Garrido S., López-Trascasa M., Rodríguez de Córdoba S. and Sánchez-Corral P
[2015]. Complement factor H, FHR-3 and FHR-1 variants associated in an extended haplotype conferring increased risk of atypical Hemolytic Uremic Syndrome. Mol. Immunol. 67:276-286
Nozal P., Garrido S., Martínez-Ara J., Picazo ML., Yébenes L., Álvarez-Doforno R., Pinto S., Rodríguez de Córdoba S. and López-Trascasa M.
[2015]. Case Report: Lupus nephritis with autoantibodies to complement alternative pathway proteins and C3 gene mutation. BMC Nephrology. 16:40
De Sousa Amorim E., Blasco M., Quintana L., Sole M., Rodríguez de Córdoba S. and Campistol JM
[2015]. Eculizumab in pregnancy-associated atypical hemolytic uremic syndrome: insights for optimizing management. J Nephrol. 28:641-645
Blasco M., Rodríguez de Córdoba S. and Campistol-Plana JM
[2015]. Atypical Hemolytic Uremic Syndrome. Med Clin (Barc). 145:438-445
Józsi M., Tortajada A., Uzonyi B., Goicoechea de Jorge E. and Rodríguez de Córdoba S.
[2015]. Factor H-related proteins determine complement-activating surfaces. Trends Immunol. 36:374-384
Zipfel P., Skerka C., Chen Q., Wiech T., Goodship T., Johnson S., Fremeaux-Bacchi V., Nester C., Rodríguez de Córdoba S., Noris M., Pickering MC. and Smith RJ
[2015]. The role of complement in C3 glomerulopathy. Mol. Immunol. 67:21-30
Nester CM., Barbour T., Rodríguez de Córdoba S., Dragon-Durey MA., Fremeaux-Bacchi V., Goodship T., Kavanagh D., Noris M., Pickering MC., Sánchez-Corral P., Skerka C., Zipfel P and Smith RJ
[2015]. Atypical aHUS: State of the Art. Mol. Immunol. 67:31-42
Martínez-Barricarte R, Heurich M, López-Perrote A, Tortajada A, Pinto S, López-Trascasa M, Sánchez-Corral P, Morgan BP, Llorca O, Harris CL, Rodríguez de Córdoba
[2015]. The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome. Mol Immunol 66:263-273
Ramos-Sevillano E, Urzainqui A, Campuzano S, Moscoso M, González-Camacho F, Domenech M, Rodríguez de Córdoba S, Sánchez-Madrid F, Brown JS, García E, Yuste J
[2015]. Pleitropic Effects of the Cell Wall Amidase LytA on Streptococcus pneumoniae Sensitivity to the Host Immune Response. Infect Immun 83:591-603
Valoti E, Alberti M, Tortajada A, García-Fernández JM, Gastoldi S, Besso L, Bresin E, Remuzzi G, Rodríguez de Córdoba S, Noris M
[2015]. A novel atypical Hemolytic Uremic Syndrome – associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation. J Am Soc Nephrol 26:209-219
Subías Hidalgo M., Tortajada A., Gastoldi S., Galbusera M., López-Perrote A., de Juana López L., González-Fernández FA., Villegas-Martínez A., Domínguez M., Llorca O., Noris M., Morgan PB. and Rodríguez de Córdoba S
[2014]. A novel antibody against human factor B that blocks formation of the C3bB proconvertase and inhibits complement activation in disease models. J Immunol 93(11):5567-75
Sánchez-Chinchilla D, Pinto S, Hoppe B, Adragna M, López L, Justa Roldan ML, Peña A, López-Trascasa M, Sánchez-Corral P, Rodríguez de Córdoba S
[2014]. Complement Mutations in Diacylglycerol Kinase-Ɛ-Associated atypical Hemolytic Uremic Syndrome. Clin J Am Soc Nephrol. 9:1611-1619
Sánchez-Moreno A., de la Cerda F., Cabrera R., Fijo J., López-Trascasa M., Bedoya R., Rodríguez de Córdoba S, Ybot-González P
[2014]. Eculizumab in Dense-Deposit Disease after renal transplantation. Pediatr Nephrol 29:2055-2059
